United States

Prothena Q2 loss per share $0.46

Tuesday, 8 Aug 2017 04:05pm EDT 

Aug 8 (Reuters) - Prothena Corporation Plc :Prothena reports second quarter 2017 financial results and provides research and development update.Q2 loss per share $0.46.Q2 revenue $26.8 million.Q2 revenue view $15.1 million -- Thomson Reuters I/B/E/S.Q2 earnings per share view $-0.88 -- Thomson Reuters I/B/E/S.Prothena Corporation PLC says we expect topline results from phase 1B mad study of PRX003 in patients with psoriasis in october.Prothena Corporation PLC says expect topline results from phase 2b pronto study of neod001 in patients with al amyloidosis in q2 of 2018. 

Company Quote

-0.13 -0.89%
4:00pm EDT